| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |